Thalidomide does not improve survival in small cell lung cancer
Thursday, July 16, 2009 - 15:35
in Health & Medicine
Treating patients with thalidomide in combination with chemotherapy for small cell lung cancer (SCLC) did not improve their survival but did increase their risk of blood clots, according to a new study published online July 16 in the Journal of the National Cancer Institute.